44 results on '"Thompson, Robert Houston"'
Search Results
2. National utilization of regional lymph node dissection among patients with kidney cancer and clinical lymphadenopathy undergoing radical nephrectomy
3. Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death
4. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy
5. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma
6. Survival following upfront cytoreductive nephrectomy versus targeted therapy for metastatic renal cell carcinoma.
7. The probability of indolent versus aggressive histology based on renal tumor size: Implications for surveillance and treatment.
8. Creation of a tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.
9. Exploring the association between renal cell carcinoma (RCC) and myeloid malignancies.
10. Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort
11. Clinicopathologic characterization and outcomes for patients with renal medullary carcinoma: Results from the National Cancer Database.
12. Survival for patients with residual tumor at radical cystectomy following chemotherapy: A matched analysis to cystectomy-only patients.
13. Association of perioperative venous thromboembolism with long-term oncologic outcomes following radical cystectomy.
14. The effect of adjuvant chemotherapy for patients with adverse pathology after neoadjuvant chemotherapy for muscle invasive bladder cancer.
15. Association of age with utilization of radical cystectomy for high-grade nonmuscle invasive bladder cancer: Results from the National Cancer Database.
16. Cryoablation of cT1 renal masses in the “healthy” patient: Early outcomes from Mayo Clinic.
17. Association of prior pelvic radiation with long-term oncologic outcomes following radical cystectomy.
18. Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes
19. Understanding the genomic underpinnings of metastatic chromophobe renal cell carcinoma.
20. Safety and efficacy of extended-duration thromboembolic prophylaxis following radical cystectomy.
21. Incidence, timing, and risk factors for infection after radical cystectomy: Results from the National Surgical Quality Improvement Program.
22. Mapping prostate cancer (CaP) recurrence after prostatectomy with c-11 choline PET/CT and 3T pelvic MRI in the contemporary era.
23. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy
24. Clinicopathologic characteristics and survival for adult renal sarcoma: A population-based study
25. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy
26. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus
27. Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach
28. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma
29. Prognostic impact of peripheral blood counts in patients with non-metastatic clear cell renal cell carcinoma.
30. Evaluation of post-operative complications and prolonged length of stay following cytoreductive nephrectomy.
31. Association and prognostic impact of peripheral blood counts with tumor programmed death ligand one expression.
32. The impact of rhabdoid differentiation on prognosis in patients with grade 4 renal cell carcinoma.
33. Association of loss of BAP1 expression in cell renal cell carcinomas with PDL1 expression.
34. Out-of-pockets costs for patients receiving targeted agents for metastatic renal cell carcinoma.
35. EAU and NCCN surveillance guidelines for bladder cancer: Do they effectively capture recurrences following cystectomy?
36. AUA and NCCN surveillance guidelines for RCC: Do they effectively capture recurrences following nephrectomy?
37. Temporal trends and factors associated with receipt of systemic therapy among patients undergoing cytoreductive nephrectomy.
38. Validation of an inverse association between programmed death ligand 1 (PDL1) and genes in the vascular endothelial growth factor (VEGF) pathway in primary clear cell renal cell (ccRCC).
39. A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis
40. Outcomes of patients with sarcomatoid renal cell carcinoma: The Mayo Clinic experience.
41. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy.
42. Chromophobe Renal Cell Carcinoma
43. General recital hour
44. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.